Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Source:http://linkedlifedata.com/resource/pubmed/id/18452778
J. Am. Coll. Cardiol.
2008
May
6
51
18
1734-41
